Indeks Rilis Pers English

NOBU ANNOUNCES RESTAURANT AND RESIDENCES IN BELLEVUE, WASHINGTON
PR Newswire
Rabu, 27 Mei

NOBU ANNOUNCES RESTAURANT AND RESIDENCES IN BELLEVUE, WASHINGTON

Travelport, Cognizant and Anthropic Collaborate to Power Travel Technology for the AI Era
PR Newswire
Rabu, 27 Mei

Travelport, Cognizant and Anthropic Collaborate to Power Travel Technology for the AI Era

Riverty Establishes Bank in Luxembourg
PR Newswire
Rabu, 27 Mei

Riverty Establishes Bank in Luxembourg

iQIYI's AI Platform Nadou Pro Surpasses 10,000 Creators, Unveils Advanced Feature Updates and Global Expansion
PR Newswire
Rabu, 27 Mei

iQIYI's AI Platform Nadou Pro Surpasses 10,000 Creators, Unveils Advanced Feature Updates and Global Expansion

Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
PR Newswire
Rabu, 27 Mei

Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV

Deutsche Rück Group continues to grow profitably
PR Newswire
Rabu, 27 Mei

Deutsche Rück Group continues to grow profitably

Tencent Announces Three Initiatives to Make Inbound Payments for International Visitors Easier Than Ever During APEC 2026
PR Newswire
Rabu, 27 Mei

Tencent Announces Three Initiatives to Make Inbound Payments for International Visitors Easier Than Ever During APEC 2026

Club Med celebrates strong performance in 2025 and primed for 2026 expansion
PR Newswire
Rabu, 27 Mei

Club Med celebrates strong performance in 2025 and primed for 2026 expansion

Kingsoft Cloud Announces Unaudited First Quarter 2026 Financial Results
PR Newswire
Rabu, 27 Mei

Kingsoft Cloud Announces Unaudited First Quarter 2026 Financial Results

Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer
PR Newswire
Rabu, 27 Mei

Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer

NOVOSENSE Presents Semiconductor Technologies for xEV Powertrain and ADAS at Automotive Engineering Exposition 2026
PR Newswire
Rabu, 27 Mei

NOVOSENSE Presents Semiconductor Technologies for xEV Powertrain and ADAS at Automotive Engineering Exposition 2026

European Travel Media and Influencers' Hainan Tour kicks off in Haikou
PR Newswire
Rabu, 27 Mei

European Travel Media and Influencers' Hainan Tour kicks off in Haikou

Desay SV Showcases AI Mobility Innovations at AEE 2026
PR Newswire
Rabu, 27 Mei

Desay SV Showcases AI Mobility Innovations at AEE 2026

Trip.com Group to Hold Annual General Meeting on June 30, 2026
PR Newswire
Rabu, 27 Mei

Trip.com Group to Hold Annual General Meeting on June 30, 2026

Bulletin from the Extraordinary General Meeting of AB Electrolux
PR Newswire
Rabu, 27 Mei

Bulletin from the Extraordinary General Meeting of AB Electrolux

TXOne Networks' Nasser Zayour on Why Execution, Not Visibility, Will Define the Next Phase of OT Security
PR Newswire
Rabu, 27 Mei

TXOne Networks' Nasser Zayour on Why Execution, Not Visibility, Will Define the Next Phase of OT Security

Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List
PR Newswire
Rabu, 27 Mei

Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List

Announcement of The Shaw Laureates 2026
PR Newswire
Rabu, 27 Mei

Announcement of The Shaw Laureates 2026

Weibo Announces Results of 2026 Annual General Meeting
PR Newswire
Rabu, 27 Mei

Weibo Announces Results of 2026 Annual General Meeting

WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
PR Newswire
Rabu, 27 Mei

WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities